(805) 483 1185

English
Español
01 Fomat_Logo_Website-min
  • Home
  • Join a Trial
    • Join a Trial
    • Healthy Volunteers
    • Participant Stories
  • Sponsors
    • Phase I Capabilities
    • Phase II- IV Capabilities
    • Diversity
  • About Us
    • About Us
    • Our Investigators
    • Careers
    • Diversity
  • Resources
    • Company Updates
    • Blogs & Updates
    • Events and Conferences
  • Contact FOMAT

Home » diabetes » Page 2

Posts tagged: diabetes

Heart disease prevention

Artificial Pancreas is a Safe and Effective Treatment for Type 1 Diabetes

April 20, 2018
by Beatriz Morales

Use of an artificial pancreas is associated with better control of blood sugar levels for people with type 1 diabetes compared with standard treatment, finds a review of the available evidence published by The BMJ today. The findings show that artif ...

Read More
0
Insulin Therapy Innovation

Cell-based Therapy for Type 1 Diabetes?

November 16, 2017
by Beatriz Morales

Cell-based Therapy for Type 1 Diabetes? Cell-based Therapy for Type 1 Diabetes has been studied by researchers at Boston Children's Hospital has successfully reversed type 1 diabetes in a mouse model by infusing blood stem cells pre-trea ...

Read More
0
Heart disease prevention

Hispanics and Diabetes Clinical Studies

July 12, 2017
by Beatriz Morales

Hispanics and Diabetes People with Hispanic or Latino backgrounds are at higher risk for developing type 2 diabetes than non-Hispanic Caucasians. This is a fact that researchers have long known. However, most research has looked at this group as a ...

Read More
0
Insulin Therapy Innovation

Diabetes Research: Team Cures Diabetes in Mice Without Side Effects

May 8, 2017
by Beatriz Morales

Diabetes Research A potential cure for Type 1 diabetes looms on the horizon in San Antonio, and the Insulin Therapy Innovation would also allow Type 2 diabetics to stop insulin shots. The discovery, made at The University of Texas Health Science Cen ...

Read More
0
Nurse measuring patient blood pressure

Over 100 New Blood Pressure Genes Could Provide Targets for Treating Hypertension

January 31, 2017
by Beatriz Morales

Scientists have found 107 new gene regions associated with high blood pressure, potentially enabling doctors to identify at-risk patients and target treatments. (Blood Pressure Genes) The study, led by Queen Mary University of London (QMUL) and Impe ...

Read More
0
Heart disease prevention

Analysis: US Deaths from Diabetes Significantly Underestimated

January 30, 2017
by Beatriz Morales

 US Deaths from Diabetes  The proportion of deaths attributable to diabetes in the U.S. is as high as 12 percent - three times higher than estimates based on death certificates suggest, according to a new analysis led by a Boston Univers ...

Read More
0
Insulin Therapy Innovation

Wearable Device Developed for Type 2 Diabetes

November 15, 2016
by Beatriz Morales

Although effective for the treatment of diabetes, exercise is sometimes difficult for overweight or elderly people. A new wearable medical device developed by Kumamoto University has been found to effect visceral fat loss and improve blood glucose (s ...

Read More
0
Anti-obesity therapy

Scientists Identify Potent New Anti-Obesity, Anti-Diabetes Target

October 13, 2016
by Beatriz Morales

Scientists Identify Promising Anti-Obesity Target for Weight Loss and Diabetes It is no secret that losing weight is difficult. Each year brings a new popular diet, “guaranteed” to succeed, yet the explosion of obesity in the United States continues ...

Read More
0
Blood sugar levels

Diabetes Sugars and Alzheimer’s Brain Plaques Potentially Linked

May 5, 2015
by Beatriz Morales

Diabetes and Alzheimer’s could have a cause-and-effect connection, according to a study published this week. Elevated blood sugar levels caused increased levels of amyloid beta, a fundamental ingredient of brain plaques in Alzheimer’s brains, in mice ...

Read More
0
Biosimilar drugs

FDA Approves Inhalable Diabetes Drug Afrezza

July 1, 2014
by Beatriz Morales

The Food and Drug Administration on Friday approved a long-delayed inhalable diabetes medication to help patients control their blood sugar levels during meals. The FDA cleared MannKind Corp.'s Afrezza, a fast-acting form of insulin for mealtime u ...

Read More
  • First
  • Previous
  • 1
  • 2
  • 3
  • Next
  • Last

Contact Us

    Upcoming Events

    Global SCRS

    Sep 29 - Oct 1, 2025

    Orlando, FL

    AAO 2025​

    Oct 18-20, 2025​

    Orlando, FL

    ACG 2025​

    Oct 24-29, 2025

    Phoenix, AZ

    Full Event List
    • Review us on Google
    • Review us on Yelp

    Conditions & Theraputic Areas

    Join a Trial

    Healthy Volunteers

    Sponsors

    Phase I Capabilities

    Phase II & III Capabilities

    Diversity

    About Us

    Careers

    Investigators

    Contact Us

    • Review us on Google
    • Review us on Yelp

    Contact Us

    FOMAT Medical Research INC,
    300 South A Street Suite 201 Oxnard, CA 93030
    (805) 483 1185
    Trials Information: [email protected]
    General Information: [email protected]

    Contact Us

    FOMAT Medical Research INC,
    300 South A Street Suite 201 Oxnard, CA 93030
    (805) 483 1185
    Trials Information: [email protected]
    General Information: [email protected]
    • Review us on Google
    • Review us on Yelp
    Proud Partner of hyperCORE
    Facebook Linkedin Instagram
    Shopping Basket
    We use cookies to ensure the best possible experience on our website. By continuing to use this site, we will assume that you are happy with itAcceptPrivacy policy